NOVALON
A bankruptcy procedure is open for NOVALON according to publications in the Belgian State Gazette. The file additionally contains 2 judicial reorganisations. The 2022 annual accounts show equity of €9.22M and a net result of €-28.09M.
| Equity | €9.22M |
| Net result | €-28.09M |
| Staff (FTE) | 5 |
| Better than sector | 36% |
Fragile profile, watch health in particular.
All 5 axes are computed from data Checked has read.
Bankruptcy opened
A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 25.2% | 45.8% | |
| Net result | €-28.09M | €-51k | |
| Equity | €9.22M | €262k | |
| Total assets | €36.58M | €2.24M |
| Fiscal year | 2022 |
|---|---|
| Deposit | volledig |
| Revenue | €14.22M |
| EBITDA | €-15.92M |
| Net profit | €-28.09M |
| Cash flow | €-23.57M |
| Staff costs | €407k |
| Income taxes | €-100k |
| Dividends | - |
| Total assets | €36.58M |
| Equity | €9.22M |
| Debt | €27.36M |
| of which ≤ 1y | €25.36M |
| of which > 1y | €2.00M |
| Working capital | €-12.42M |
| Employees (FTE) | 5.0 |
| 2022 | |
|---|---|
| Current ratio | 0.51 |
| Quick ratio | 0.28 |
| Working capital ratio | -33.9% |
| Solvency | 25.2% |
| Debt / equity | 2.97 |
| Long-term debt ratio | 0.22 |
| Interest coverage | -2.05 |
| Gross margin | 49.3% |
| Net margin | -197.6% |
| ROA | -76.8% |
| ROE | -304.7% |
| EBITDA margin | -112.0% |
| Days sales outstanding | 121d |
| Days payable outstanding | 946d |
| Inventory turnover | 1.24 |
| Days inventory (DSI) | 295d |
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €36.58M |
| Fixed assets | 21/28 | €23.64M |
| Intangible fixed assets | 21 | €23.57M |
| Tangible fixed assets | 22/27 | €64k |
| Financial fixed assets | 28 | €91 |
| Current assets | 29/58 | €12.94M |
| Stocks & contracts in progress | 3 | €5.83M |
| Amounts receivable within one year | 40/41 | €6.60M |
| Cash & bank | 54/58 | €18k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €36.58M |
| Equity | 10/15 | €9.22M |
| Contributions / capital | 10/11 | €35.63M |
| Reserves | 13 | €6k |
| Accumulated profits (losses) | 14 | €-28.09M |
| Amounts payable | 17/49 | €27.36M |
| Amounts payable after one year | 17 | €2.00M |
| Amounts payable within one year | 42/48 | €25.36M |
| Trade debts payable within one year | 44 | €18.68M |
| Income statement | ||
| Turnover | 70 | €14.22M |
| Operating result | 9901 | €-20.45M |
| Financial income | 75 | €223k |
| Financial charges | 65 | €7.97M |
| Result before taxes | 9903 | €-28.19M |
| Income taxes | 67/77 | €-100k |
| Net result for the period | 9904 | €-28.09M |
| Result to be appropriated | 9905 | €-28.09M |
-
C2M4E SRLLegal entityDirectorState Gazette act 24054761 (03-04-2024)Current03-04-2024 → present
-
SRL Alius ModiLegal entityDirectorState Gazette act 22100687 (23-08-2022)Current23-08-2022 → present
-
Van Rompay Management BVLegal entityManaging directorState Gazette act 22100687 (23-08-2022)Current07-05-2021 → present
3 events
- 23-08-2022 Appointed· Managing director
- 07-05-2021 Appointed· Director
- 07-05-2021 Appointed· Managing director
Historic, not recently confirmed (6)
-
Francesco FornieriReprésentant permanent administrateurState Gazette act 17049369 (06-04-2017)Not recently confirmedlast confirmed in an act from 2017
-
Guy DebruyneReprésentant permanent administrateurState Gazette act 17049369 (06-04-2017)Not recently confirmedlast confirmed in an act from 2017
-
SA CG CubeLegal entityDirectorState Gazette act 17049369 (06-04-2017)Not recently confirmedlast confirmed in an act from 2017
2 events
- 07-05-2021 Resigned· Director
- 06-04-2017 Appointed· Director
-
SPRL YIMALegal entityDirectorState Gazette act 17049369 (06-04-2017)Not recently confirmedlast confirmed in an act from 2017
2 events
- 06-04-2017 Appointed· Director
- 13-07-2011 Resigned· Director
-
SA UTERON PHARMALegal entityManaging directorState Gazette act 11106785 (13-07-2011)Not recently confirmedlast confirmed in an act from 2011
2 events
- 13-07-2011 Appointed· Managing director
- 13-07-2011 Appointed· Daily management delegate
-
SPRL MAJOCEPILegal entityDirectorState Gazette act 11106785 (13-07-2011)Not recently confirmedlast confirmed in an act from 2011
Former directors (10)
-
CMM&C SrlLegal entityDaily management delegateState Gazette act 24054761 (03-04-2024)Former03-04-2024 → 05-07-2024
2 events
- 05-07-2024 Resigned· Daily management delegate
- 03-04-2024 Appointed· Daily management delegate
-
Xavier PaoliDaily management delegateState Gazette act 24054761 (03-04-2024)Former03-04-2024 → 05-07-2024
2 events
- 05-07-2024 Resigned· Daily management delegate
- 03-04-2024 Appointed· Daily management delegate
-
Bronzet Management SrlLegal entityDirectorState Gazette act 23156921 (07-12-2023)Former07-12-2023 → 03-04-2024
3 events
- 03-04-2024 Resigned· Managing director
- 07-12-2023 Appointed· Director
- 07-12-2023 Appointed· Managing director
-
David Horn SolomonDirectorState Gazette act 23098109 (31-07-2023)Former31-07-2023 → 07-12-2023
4 events
- 07-12-2023 Resigned· Director
- 07-12-2023 Resigned· Managing director
- 31-07-2023 Appointed· Director
- 31-07-2023 Appointed· Managing director
-
Leon Van RompayDirectorState Gazette act 23098109 (31-07-2023)Former- → 31-07-2023
-
Yima SRLLegal entityDirectorState Gazette act 22100687 (23-08-2022)Former- → 23-08-2022
2 events
- 23-08-2022 Resigned· Director
- 07-05-2021 Resigned· Managing director
-
Jean-Michel FoidartDirectorState Gazette act 17049369 (06-04-2017)Former- → 06-04-2017
-
SPRL SVR INVESTLegal entityDirectorState Gazette act 11106785 (13-07-2011)Former13-07-2011 → 06-04-2017
2 events
- 06-04-2017 Resigned· Director
- 13-07-2011 Appointed· Director
-
François FORNIERIDirectorState Gazette act 11106785 (13-07-2011)Former- → 13-07-2011
-
SPRL MAJOCЕRILegal entityDirectorState Gazette act 11106785 (13-07-2011)Former- → 13-07-2011
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Christophe PelzerCurrent Commissaire |
- | 06-01-2023 → present |
| Cédric ANTONELLI Commissaire |
- | 29-08-2018 → 06-01-2023 |
| Felix Fank Commissaire succeeded by Christophe Pelzer in 2023 |
- | 08-01-2016 → 06-01-2023 |
| SCRL BDO Réviseurs d'Entreprises Commissaire succeeded by Christophe Pelzer in 2023 |
- | 08-01-2016 → 06-01-2023 |
| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | YVES GODFROID RUE DES AUGUSTINS 32,
4000 LIEGE 1 |
25-07-2024 → present | Belgian State Gazette |
| Curator | FRANCOIS MINON RUE DES AUGUSTINS 32, 4000 LIEGE 1- francois.minon@henry-
mersch.be |
25-07-2024 → present | Belgian State Gazette |
| NACE primary | Vervaardiging van overige farmaceutische producten(21209) |
| Legal form | Public limited company(014) |
| Incorporation | 03-11-2005 |
| Status | Active |
| Postal code | 4000 |
| First BS signal | 25-04-2024 |
| Latest BS signal | 31-07-2024 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62810C0909/00G000 | Wallonia | 126 m² | 1 · 43 m² | 16.9 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-07-2024 2 resigning
- Xavier Paoli, Dagelijks bestuur
- CMM&C Srl, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Xavier Paoli",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "CMM\u0026C Srl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}03-04-2024 3 directors appointed, 1 resigning
- C2M4E SRL, Bestuurder
- Xavier Paoli, Dagelijks bestuur
- CMM&C Srl, Dagelijks bestuur
- Bronzet Management Srl, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bronzet Management Srl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "C2M4E SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Xavier Paoli",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "CMM\u0026C Srl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}07-12-2023 2 directors appointed, 2 resigning
- Bronzet Management Srl, Bestuurder
- Bronzet Management Srl, Gedelegeerd bestuurder
- David Horn Solomon, Bestuurder
- David Horn Solomon, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "David Horn Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bronzet Management Srl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "David Horn Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bronzet Management Srl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}31-07-2023 2 directors appointed, 1 resigning
- David Horn Solomon, Bestuurder
- David Horn Solomon, Gedelegeerd bestuurder
- Leon Van Rompay, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Leon Van Rompay",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "David Horn Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "David Horn Solomon",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}06-01-2023 1 director appointed, 1 resigning
- Christophe Pelzer, Commissaire
- Cédric Antonelli, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Christophe Pelzer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaire",
"person": {
"rrn": null,
"name": "C\u00E9dric Antonelli",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}06-01-2023 Capital increase of €114,021,734 to €120,519,538.25
- €6.497.804,25 → €120.519.538,25
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 120519538.25,
"delta_eur": 114021734.0,
"before_eur": 6497804.25,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}23-08-2022 2 directors appointed, 1 resigning
- SRL Alius Modi, Bestuurder
- Van Rompay Management BV, Gedelegeerd bestuurder
- Yima SRL, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yima SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administratrice",
"person": {
"rrn": null,
"name": "SRL Alius Modi",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Van Rompay Management BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}25-01-2022 Cédric ANTONELLI appointed as commissaire
- Cédric ANTONELLI, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "C\u00E9dric ANTONELLI",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}05-07-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}07-05-2021 2 directors appointed, 2 resigning
- Van Rompay Management BV, Bestuurder
- Van Rompay Management BV, Gedelegeerd bestuurder
- CG Cube SA, Bestuurder
- Yima SRL, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "CG Cube SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Van Rompay Management BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Yima SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Van Rompay Management BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "Novalon"
}
}26-08-2019 Capital increase of €76,484.20 to €137,984.20
- €61.500 → €137.984,20
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 137984.2,
"delta_eur": 76484.20000000001,
"before_eur": 61500,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}27-06-2019 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Fran\u00E7ois Fomieri",
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2019-06-27",
"filing_date": "2019-06-14",
"act_kind_objet": "D\u00E9p\u00F4t du projet d\u0027apport de branche d\u0027activit\u00E9s du 12 juin 2019"
},
"decision": {
"body": "bestuursorgaan",
"act_date": "2019-06-12",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0877.126.557",
"name": "Mithra Pharmaceuticals SA",
"role": "contributor",
"address": "Rue Saint Georges 5-7 4000 Li\u00E8ge",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "Novalon SA",
"role": "recipient",
"address": "Rue Saint Georges 5-7 4000 Li\u00E8ge",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"75",
"760 \u00A73"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Le projet concerne l\u0027apport d\u0027une branche d\u0027activit\u00E9s de Mithra Pharmaceuticals SA \u00E0 Novalon SA. Il s\u0027agit d\u0027une partie du patrimoine, notamment des activit\u00E9s li\u00E9es \u00E0 la recherche et au d\u00E9veloppement de m\u00E9dicaments dans le domaine des maladies rares.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "Mithra Pharmaceuticals SA",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Fran\u00E7ois Fomieri",
"org_rep_person_name": null
},
"summary_narrative": "Le projet d\u0027apport de branche d\u0027activit\u00E9s du 12 juin 2019, \u00E9tabli conjointement par les organes de gestion de Mithra Pharmaceuticals SA et de Novalon SA, a \u00E9t\u00E9 d\u00E9pos\u00E9 aux annexes du Moniteur belge conform\u00E9ment \u00E0 l\u0027article 75 du Code des soci\u00E9t\u00E9s. L\u0027op\u00E9ration vise le transfert d\u0027une branche d\u0027activit\u00E9s li\u00E9es \u00E0 la recherche et au d\u00E9veloppement de m\u00E9dicaments rares.",
"co_filed_documents": [],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}29-08-2018 Cédric ANTONELLI appointed as commissaire
- Cédric ANTONELLI, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "C\u00E9dric ANTONELLI",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}15-01-2018 Capital increase of €8,000,000 to €8,061,500
- €61.500 → €8.061.500
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8061500,
"delta_eur": 8000000,
"before_eur": 61500,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}06-04-2017 4 directors appointed, 2 resigning
- SPRL YIMA, Bestuurder
- Francesco Fornieri, Représentant permanent administrateur
- SA CG Cube, Bestuurder
- Guy Debruyne, Représentant permanent administrateur
- Jean-Michel Foidart, Bestuurder
- SPRL SVR INVEST, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Michel Foidart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL SVR INVEST",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL YIMA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent administrateur",
"person": {
"rrn": null,
"name": "Francesco Fornieri",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SA CG Cube",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent administrateur",
"person": {
"rrn": null,
"name": "Guy Debruyne",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON VISION LLO"
}
}03-06-2016 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Joris De Wolf",
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-06-03",
"filing_date": "2016-05-20",
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-05-19",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0466.526.646",
"name": "Mithra Pharmaceuticals SA",
"role": "acquiring",
"address": "Rue Saint-Georges 5, 4000 Li\u00E8ge",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0877.126.557",
"name": "Novalon",
"role": "absorbed",
"address": "Rue Saint-Georges 5, 4000 Li\u00E8ge",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"719",
"722 \u00A76",
"676 1\u00B0"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine, actif et passif, de Novalon est transf\u00E9r\u00E9e \u00E0 Mithra Pharmaceuticals par dissolution sans liquidation.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "Novalon",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Joris De Wolf",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption de Novalon SA par Mithra Pharmaceuticals SA a \u00E9t\u00E9 approuv\u00E9 par les conseils d\u0027administration des deux soci\u00E9t\u00E9s le 19 mai 2016. Cette op\u00E9ration, qualifi\u00E9e d\u0027op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption, s\u0027inscrit dans une r\u00E9organisation du groupe Mithra. Mithra Pharmaceuticals d\u00E9tient d\u00E9j\u00E0 l\u0027int\u00E9gralit\u00E9 des actions de Novalon, ce qui permet une fusion simplifi\u00E9e sans \u00E9mission de nouvelles actions ni rapport d\u0027\u00E9change. Le d\u00E9p\u00F4t du projet au greffe a eu lieu le 20 mai 2016, avec une prise d\u0027effet pr\u00E9vue le 15 juillet 2016.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}08-01-2016 2 directors appointed
- Felix Fank, Commissaire
- SCRL BDO Réviseurs d'Entreprises, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Commissaire",
"person": {
"rrn": null,
"name": "Felix Fank",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Commissaire",
"person": {
"rrn": null,
"name": "SCRL BDO R\u00E9viseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}27-11-2015 Capital increase of €411,910.54 to €1,486,310.54
- €1.074.400 → €1.486.310,54
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1486310.54,
"delta_eur": 411910.54000000004,
"before_eur": 1074400.0,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}13-07-2011 4 directors appointed, 3 resigning
- SPRL SVR INVEST, Bestuurder
- SA UTERON PHARMA, Gedelegeerd bestuurder
- SPRL MAJOCEPI, Bestuurder
- SA UTERON PHARMA, Dagelijks bestuur
- François FORNIERI, Bestuurder
- SPRL YIMA, Bestuurder
- SPRL MAJOCЕRI, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Fran\u00E7ois FORNIERI",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL YIMA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL MAJOC\u0415RI",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL SVR INVEST",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "SA UTERON PHARMA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SPRL MAJOCEPI",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "SA UTERON PHARMA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0877.126.557",
"name_full": "NOVALON"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | NOVALON |